Standards Desk · recorded August 2026
Seller record · telehealth service · joinmochi.com
Mochi Health
A telehealth service selling compounded and brand GLP-1 drugs. It names four affiliated medical practices, and it lets the buyer choose the filling pharmacy.
Passes 6 of 8 criteria. Recorded against Standard v1.1, August 2026.
Operating entity Mochi Health Corp., Inc.
Dispositions at a glance
Evidence, criterion by criterion
What was read, where, and on what date, for each disposition in the table above.
S1PASSFour affiliated medical practices are named, and no prescription issues unless a licensed Mochi clinician has assessed the buyer and written it.Source: joinmochi.com/termsandconditions · read August 2026. S2PASSThe order path was walked from the home page and stopped at the first eligibility question, which asks the buyer's primary weight loss goal.Source: app.joinmochi.com/eligibility · read August 2026. S3FAILThe buyer compares pharmacies and may fill at any pharmacy of choice, and no filling facility is named on any page read.Source: joinmochi.com/termsandconditions, joinmochi.com/weight-loss · read August 2026. S4PASSCompounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality, printed directly under the price.Source: joinmochi.com/medications/compounded-semaglutide · read August 2026. S5FAILNo certificate, lot report or test document appears on the product page, the terms, or among the 2,262 addresses the sitemap lists.Source: joinmochi.com/sitemap.xml · read August 2026. S6PASS333 Bush St., Suite #1200, San Francisco, CA 94104 in the terms; the privacy policy gives 161 Natoma St, San Francisco, CA 94105 instead.Source: joinmochi.com/termsandconditions, joinmochi.com/privacy-policy · read August 2026. S7PASSCompounded semaglutide is printed starting at 60 dollars, with membership at 39 dollars for the first month and 79 dollars per month afterward.Source: joinmochi.com/medications/compounded-semaglutide · read August 2026. S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index · read August 2026. Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, brand Zepbound, brand Wegovy, brand Ozempic, metformin, hair loss medications.
Dispositions recorded against Standard v1.1, August 2026. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.